How Eli Lilly’s new platform TuneLab codevelops AI models with biotech

The latest episode of Data in Biotech is now live! 

Dr. Aliza Apple, VP of Catalyze360 AI/ML at Eli Lilly, joins Ross Katz to unveil TuneLab — a first-of-its-kind federated learning platform accelerating preclinical drug discovery.

Why it matters:

>> Access Lilly’s “billion-dollar” models—trained on decades of pharma data—without sharing raw data
>> Federated learning = IP protection + real collaboration across orgs
>>Two real-world wins today: small-molecule ADME and antibody developability

Listen now!

Apple Podcasts
Spotify
YouTube

Join newsletter
Stay up to date with new case studies. We promise no spam, just good content.

More blog posts

see all